Plutux
$0.72
-0.85%
2026-09-02 16:00:00 EDT+$0.00
Healthcare
Medical - Instruments & Supplies
AMEX
Active Trading

Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for ...

Price Action

$0.72
+0.00%+$0.00
High
Low
52W High-36.8%
Rel. vol
Interval
Range4.6h
VolumeSMA5SMA10
Retractable Technologies, Inc. (NYSE American: RVP) is a pioneer in automated retraction technology, dedicated to enhancing healthcare worker safety and reducing infectious disease transmission. Founded by Thomas J. Shaw in 1994, the company designs, manufactures, and markets a range of safety medical devices, primarily syringes, that feature automated retraction to ...Retractable Technologies, Inc. (NYSE American: RVP) is a pioneer in automated retraction technology, dedicated to enhancing healthcare worker safety and reducing infectious disease transmission. Founded by Thomas J. Shaw in 1994, the company designs, manufactures, and markets a range of safety medical devices, primarily syringes, that feature automated retraction to minimize needlestick injuries. Their product portfolio includes VanishPoint® insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes, Luer Caps, blood collection sets, IV catheters, and EasyPoint needles. These products are distributed through a network of general and specialized distributors, international partners, and a direct sales force across the Americas and other regions. Financially, RVP has faced recent challenges, with a market cap of approximately $20 million and a negative net income margin of -16.9% over the trailing twelve months. The company's revenue per share stands at $1.24, but its operating cash flow is negative, and it has a high debt-to-equity ratio of only 0.013, indicating low leverage. Despite this, RVP maintains a strong current ratio of 5.74, suggesting ample short-term liquidity. The company invests in R&D, with 1.8% of revenue allocated to research, and focuses on cost-effective healthcare solutions. Key leadership includes founder and CEO Thomas Shaw, who recently purchased additional shares, demonstrating confidence. The company employs over 200 people, many with over two decades of service, and is committed to its mission of reducing the worldwide spread of infectious diseases. With a strong intellectual property portfolio and a focus on innovation, RVP aims to leverage regulatory trends favoring safety devices to drive future growth.
Founded
1994
Employees
198
CEO
Thomas J. Shaw
Full Name
Retractable Technologies, Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
ROE
-4.59%
Market Cap
$0.02B
Current Ratio
4.93
WACC
10.16%
ROIC
-2.57%

Contact Information

972 294 1010
511 Lobo Lane, Little Elm, TX 75068-5295

Related stocksMedical - Instruments & Supplies

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026